Skip to content

A Clinical Study to Assess the Additional Benefit of Ayurvedic Eye Drops Along with Oral Ayurvedic Medicines in the Treatment of Dry Eye Disease.

Evaluation of the Add-On Effect of Shunthyadi Ghrita Manda Eye Drops with Vibhitakadi Ghrita and Triphaladi Compound orally in the management of Shushkakshipaka (Dry Eye Syndrome): An Open-Label, Two-Arm Randomized Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103452
Enrollment
64
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex aged between 18 to 60 years. 2. The patient capable and willing to take part in the research. 3. Individuals who exhibit lakshana of Shushkakshipaka and signs and symptoms of dry eyes syndromre.

Exclusion criteria

Exclusion criteria: 1. Severe cases of dry eye disease accompanied by uveitis, glaucoma and corneal ulcers, among other consequences. 2. Allergies and inflammations, such as giant papillary conjunctivitis, vernal keratoconjunctivitis, and acute conjunctivis 3. Patients suffering from major systemic illness necessitating long term treatment ex. Psycho-epileptic drug users etc. 4. History of hypersensitivity of the trial drug or any of its ingredients. 5. Patients on steroids, oral contraceptive pills, oestrogen replacement therapy, or any other medication such as antispasmodic drugs such as Atropine that may adversely affect the outcome of study 6. Sjogren syndrome or other systemic autoimmune disease causing dry eye 7. Lactating and Pregnant women.

Design outcomes

Primary

MeasureTime frame
Reduction in foreign body sensation in Shushkakshipaka w.s.r. to Dry eye syndrome assessed through specific questionnaire Timepoint: Evaluation of the patient during the treatment on 0th,14th,28th ,42nd day

Secondary

MeasureTime frame
1 Overall improvement in the rest other symptoms & quality of life related to ocular health 2 Increase in Schirmer s test result and Tear Break Up Time (BUT) 3 Changes in serum levels of pro inflammatory cytokines (IF FEASIBLE) Timepoint: Evaluation of the patient during the treatment on 0th,14th,28th ,42nd day

Countries

India

Contacts

Public ContactDr Muskan Bajaj

All India Institute of Ayurveda

bhatrajma2008@gmail.com9560788850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026